| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.3 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.096 | 0.3 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | pitstop2 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.3 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |